Delfa provides an AI-native operating system to automate clinical trial operations, starting with patient recruitment. Its platform uses multilingual AI agents to outreach via phone, SMS, and chat to pre-screen eligibility, answer questions, schedule visits, and send reminders, while centralizing communications and data and syncing with CTMS. Delfa differentiates itself through end-to-end automation, multilingual agents, and tight CTMS integration, serving clinical research site networks with real-world case results. Its goal is to become a full-stack operating system for clinical trials that enables smarter site selection and automated study start-up to reduce enrollment delays.
Company Size
11-50
Company Stage
Seed
Total Funding
$3.8M
Headquarters
London, United Kingdom
Founded
2024
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?